Could new scans revolutionize nasopharyngeal cancer care?
NCT ID NCT07137052
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study will test whether two new types of PET/CT scans can more accurately stage nasopharyngeal carcinoma and predict how well patients respond to immunotherapy before treatment. About 732 participants aged 18-70 with newly diagnosed, untreated cancer will receive the scans. The goal is to see if these imaging techniques improve staging accuracy and early prediction of treatment success.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Gallium-68 labeled tracers (68Ga-FAPI-LM3 and 68Ga-PD-L1) for PET/CT imaging
What this could lead to
If successful, this could lead to more accurate staging and earlier prediction of how well immunotherapy works for nasopharyngeal carcinoma, helping doctors tailor treatments.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. The imaging techniques are still experimental and may not prove better than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••